Dmitri Bobilev
Impact in
- Infectious Diseases top 10%
- Clostridium difficile and Clostridium perfringens research
- Gastroenterology top 10%
- Gastrointestinal motility and disorders
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 4
- PARP inhibition in cancer therapy 2
- Lung Cancer Research Studies 2
-
- Gut microbiota and health 3
- Cancer therapeutics and mechanisms 2
- Co-authors
- Jason M. Norman (5 shared papers)Bernat Olle (5 shared papers)Rajita Menon (3 shared papers)David Geffen (2 shared papers)Sahil Khanna (2 shared papers)Jeffrey L. Silber (3 shared papers)Candida Fratazzi (2 shared papers)Mary Ruisi (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (2 papers)Gastroenterology (2 papers)Cancer Research (2 papers)Neuro-Oncology (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Dmitri Bobilev
19 papers receiving 312 citations
Dmitri Bobilev's Hit Papers
Peers
Comparison fields: 5 of 59
- Infectious Diseases 109
- Gastroenterology 31
- Oncology 70
- Pulmonary and Respiratory Medicine 58
- Molecular Biology 134
Countries citing papers authored by Dmitri Bobilev
This map shows the geographic impact of Dmitri Bobilev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitri Bobilev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitri Bobilev more than expected).
Fields of papers citing papers by Dmitri Bobilev
This network shows the impact of papers produced by Dmitri Bobilev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitri Bobilev. The network helps show where Dmitri Bobilev may publish in the future.
Co-authors
The 25 scholars most cited alongside Dmitri Bobilev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection Hit paper breakdown → | 2023 | 129 |
| 2 | 2014 | 27 | |
| 3 | 2015 | 27 | |
| 4 | 2006 | 22 | |
| 5 | Disseminated intravascular coagulation at presentation of advanced gastric cancer. | 2006 | 22 |
| 6 | 2019 | 18 | |
| 7 | 2014 | 13 | |
| 8 | 2019 | 12 | |
| 9 | 2017 | 9 | |
| 10 | 2017 | 7 | |
| 11 | 2016 | 7 | |
| 12 | 2020 | 4 | |
| 13 | 2013 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2005 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2016 | 1 | |
| 20 | 2022 | 0 |
About Dmitri Bobilev
Dmitri Bobilev is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 315 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Gut microbiota and health (3 papers), Ovarian cancer diagnosis and treatment (2 papers), interferon and immune responses (2 papers), PARP inhibition in cancer therapy (2 papers), Lung Cancer Research Studies (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Infectious Diseases (109 citations), Gastroenterology (31 citations), Oncology (70 citations), Pulmonary and Respiratory Medicine (58 citations) and Molecular Biology (134 citations). Dmitri Bobilev has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Jason M. Norman, Bernat Olle, Rajita Menon, David Geffen, Sahil Khanna, Jeffrey L. Silber, Candida Fratazzi, Mary Ruisi, Jeremiah J. Faith and Thomas Louie. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Gastroenterology, Cancer Research and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.